Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations Pharmaceutical Investing
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company Pharmaceutical Investing
Knight Therapeutics Inc. places No. 22 on The Globe and Mail's fourth-annual ranking of Canada's Top Growing Companies Pharmaceutical Investing
Medtronic announces closing of public offering of Euro3.5 billion of senior notes Medical Device Investing
Medtronic receives FDA clearance for expanded indication of LINQ II insertable cardiac monitor for use in pediatric patients ages 2 and older Medical Device Investing
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area Pharmaceutical Investing
TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure Medical Device Investing
